JPS5940131B2 - 無髄歯科学治療用ペ−スト - Google Patents
無髄歯科学治療用ペ−ストInfo
- Publication number
- JPS5940131B2 JPS5940131B2 JP53045436A JP4543678A JPS5940131B2 JP S5940131 B2 JPS5940131 B2 JP S5940131B2 JP 53045436 A JP53045436 A JP 53045436A JP 4543678 A JP4543678 A JP 4543678A JP S5940131 B2 JPS5940131 B2 JP S5940131B2
- Authority
- JP
- Japan
- Prior art keywords
- paste
- composition
- mixture
- zinc oxide
- thymol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 claims abstract description 44
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 28
- 210000004262 dental pulp cavity Anatomy 0.000 claims abstract description 27
- 238000011049 filling Methods 0.000 claims abstract description 25
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims abstract description 18
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 16
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 16
- 229960000846 camphor Drugs 0.000 claims abstract description 16
- 229930008380 camphor Natural products 0.000 claims abstract description 16
- 239000011787 zinc oxide Substances 0.000 claims abstract description 14
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940090668 parachlorophenol Drugs 0.000 claims abstract description 13
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 10
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000005770 Eugenol Substances 0.000 claims abstract description 9
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960002217 eugenol Drugs 0.000 claims abstract description 9
- 230000001112 coagulating effect Effects 0.000 claims abstract description 5
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 13
- 239000005844 Thymol Substances 0.000 claims description 11
- 229960000790 thymol Drugs 0.000 claims description 11
- 239000000645 desinfectant Substances 0.000 claims description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 8
- 229940041616 menthol Drugs 0.000 claims description 8
- 230000000202 analgesic effect Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000005526 vasoconstrictor agent Substances 0.000 claims description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical class CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 abstract description 15
- LHBQLURVBODGOO-UHFFFAOYSA-N 2-iodo-3-(iodomethyl)-6-propan-2-ylphenol Chemical compound CC(C)C1=CC=C(CI)C(I)=C1O LHBQLURVBODGOO-UHFFFAOYSA-N 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000979 retarding effect Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 210000005239 tubule Anatomy 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 206010011732 Cyst Diseases 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 201000004328 Pulpitis Diseases 0.000 description 1
- 206010037464 Pulpitis dental Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000010758 granulomatous inflammation Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004053 periapical tissue Anatomy 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61K6/889—Polycarboxylate cements; Glass ionomer cements
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dental Preparations (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7712649A FR2387647A1 (fr) | 1977-04-20 | 1977-04-20 | Pate de traitement endodontique pour l'obturation canalaire de dents |
| FR000007712649 | 1977-04-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS549491A JPS549491A (en) | 1979-01-24 |
| JPS5940131B2 true JPS5940131B2 (ja) | 1984-09-28 |
Family
ID=9189956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53045436A Expired JPS5940131B2 (ja) | 1977-04-20 | 1978-04-19 | 無髄歯科学治療用ペ−スト |
Country Status (20)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021519333A (ja) * | 2018-03-27 | 2021-08-10 | デンツプライ シロナ インコーポレイテッド | 抗炎症洗浄液および充填組成物を用いる歯髄治療および根管充填の方法 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01294609A (ja) * | 1988-02-09 | 1989-11-28 | Toyo Kagaku Kenkyusho:Kk | 歯科用根管充填用シーラー |
| US5472684A (en) * | 1993-06-02 | 1995-12-05 | Colgate Palmolive Company | Oral compositions for plaque and gingivitis |
| RU2144348C1 (ru) * | 1999-04-13 | 2000-01-20 | Тимофеев Владимир Николаевич | Паста тимофеева для пломбирования корневых каналов зубов |
| US6472454B1 (en) | 1999-10-22 | 2002-10-29 | Kerr Corporation | Endodontic dental compositions |
| US6353041B1 (en) | 1999-10-22 | 2002-03-05 | Kerr Corporation | Dental compositions |
| DE19962470A1 (de) * | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
| US20040053201A1 (en) * | 2002-09-17 | 2004-03-18 | Dovgan Joseph S. | Antibacterial sponges for use in endodontic procedures and methods of use |
| CL2009001747A1 (es) * | 2009-08-20 | 2010-09-10 | Galvan Gonzalez Tomas Bernardo | Composicion farmaceutica que comprende 0,05-0,3% de peroxido de hidrogeno, 0,001-0,03% de eugenol, 0,001-0,01% de alcanfor, 0,001-0,5% de una sal de zinc u otros metales pesados definidos, 1-1,2% de fluoruro de sodio, 2-7% de xilitol y excipientes; metodo de preparacion; uso para prevenir y/o tratar enfermedades orales. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US987451A (en) * | 1906-05-28 | 1911-03-21 | Lucien Eilertsen | Process for preparing and coloring plastic substances used as bases in dental prosthesis. |
| US1900237A (en) * | 1929-07-22 | 1933-03-07 | Vern S Harshman | Dental cement and process of making dental cement |
| US2516438A (en) * | 1947-05-26 | 1950-07-25 | Norton L Wheeler | Dental pulp capping preparation |
-
1977
- 1977-04-20 FR FR7712649A patent/FR2387647A1/fr active Granted
-
1978
- 1978-03-28 US US05/891,040 patent/US4184879A/en not_active Expired - Lifetime
- 1978-04-04 GB GB13168/78A patent/GB1561565A/en not_active Expired
- 1978-04-05 CH CH366578A patent/CH630523A5/fr not_active IP Right Cessation
- 1978-04-13 NL NLAANVRAGE7803938,A patent/NL178654C/xx not_active IP Right Cessation
- 1978-04-13 YU YU00889/78A patent/YU88978A/xx unknown
- 1978-04-17 LU LU79447A patent/LU79447A1/xx unknown
- 1978-04-17 PT PT67909A patent/PT67909B/pt unknown
- 1978-04-18 HU HU78LA935A patent/HU176126B/hu unknown
- 1978-04-18 AT AT273678A patent/AT362072B/de not_active IP Right Cessation
- 1978-04-18 CA CA301,365A patent/CA1107650A/fr not_active Expired
- 1978-04-19 ES ES468925A patent/ES468925A1/es not_active Expired
- 1978-04-19 DK DK170878A patent/DK170878A/da active IP Right Grant
- 1978-04-19 PL PL1978206217A patent/PL125420B1/pl unknown
- 1978-04-19 JP JP53045436A patent/JPS5940131B2/ja not_active Expired
- 1978-04-19 SE SE7804435A patent/SE436683B/sv not_active IP Right Cessation
- 1978-04-19 BE BE6046435A patent/BE866160A/xx not_active IP Right Cessation
- 1978-04-19 IE IE772/78A patent/IE46619B1/en unknown
- 1978-04-19 NO NO781371A patent/NO149912C/no unknown
- 1978-04-20 IT IT22561/78A patent/IT1094464B/it active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021519333A (ja) * | 2018-03-27 | 2021-08-10 | デンツプライ シロナ インコーポレイテッド | 抗炎症洗浄液および充填組成物を用いる歯髄治療および根管充填の方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| IT1094464B (it) | 1985-08-02 |
| HU176126B (en) | 1980-12-28 |
| SE436683B (sv) | 1985-01-21 |
| CH630523A5 (fr) | 1982-06-30 |
| CA1107650A (fr) | 1981-08-25 |
| JPS549491A (en) | 1979-01-24 |
| NL178654B (nl) | 1985-12-02 |
| FR2387647A1 (fr) | 1978-11-17 |
| FR2387647B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1982-02-12 |
| NO149912C (no) | 1984-07-18 |
| IT7822561A0 (it) | 1978-04-20 |
| DK170878A (da) | 1978-10-21 |
| SE7804435L (sv) | 1978-10-21 |
| AT362072B (de) | 1981-04-27 |
| PT67909A (fr) | 1978-05-01 |
| ATA273678A (de) | 1980-09-15 |
| ES468925A1 (es) | 1978-12-16 |
| GB1561565A (en) | 1980-02-27 |
| NL178654C (nl) | 1986-05-01 |
| YU88978A (en) | 1984-04-30 |
| PT67909B (fr) | 1979-10-15 |
| PL206217A1 (pl) | 1979-06-04 |
| NL7803938A (nl) | 1978-10-24 |
| PL125420B1 (en) | 1983-05-31 |
| LU79447A1 (fr) | 1979-05-25 |
| BE866160A (fr) | 1978-10-19 |
| NO781371L (no) | 1978-10-23 |
| IE46619B1 (en) | 1983-08-10 |
| NO149912B (no) | 1984-04-09 |
| IE780772L (en) | 1978-10-20 |
| US4184879A (en) | 1980-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sonmez et al. | A comparison of four pulpotomy techniques in primary molars: a long-term follow-up | |
| Vidal et al. | Apical closure in apexification: a review and case report of apexification treatment of an immature permanent tooth with biodentine | |
| Heithersay | Treatment of invasive cervical resorption: An analysis of results using topical application of trichioracetic acid, curettage, and restoration. | |
| Loel | Use of acid cleanser in endodontic therapy | |
| Thomas et al. | Elimination of infection in pulpectomized deciduous teeth: a short-term study using iodoform paste | |
| Yildirim et al. | Clinical and radiographic evaluation of the effectiveness of formocresol, mineral trioxide aggregate, Portland cement, and enamel matrix derivative in primary teeth pulpotomies: a two year follow-up | |
| El Meligy et al. | Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis) | |
| Nosrat et al. | Calcium-enriched mixture cement as artificial apical barrier: A case series | |
| US4895517A (en) | Methods for performing vital dental pulpotomy | |
| Walton | Intracanal medicaments | |
| Roane et al. | Successful management of a perforated mandibular molar using amalgam and hydroxylapatite | |
| JPS5940131B2 (ja) | 無髄歯科学治療用ペ−スト | |
| Baratto‐Filho et al. | Treatment of invasive cervical resorption with MTA: case report | |
| Fagundes et al. | Indirect pulp treatment in a permanent molar: case reort of 4-year follow-up | |
| Nematollahi et al. | Comparison of electrosurgical pulpotomy with zinc oxide eugenol or zinc polycarboxylate cements sub-base | |
| Plotino et al. | Complications due to root canal filling procedures | |
| Grossman et al. | Paresthesia from N2: report of a case | |
| Goyal et al. | The Clinical, Radiographic and Histological evaluation of three different concentrations of Formocresol as a pulpotomy agent | |
| Manohar et al. | A comparative evaluation of four regenerative materials for pulpotomy in primary molars: An: in vivo: study | |
| Khan et al. | Mineral trioxide aggregate use in pediatric dentistry: A literature review | |
| Abrams et al. | Periodontal changes following coronal/root perforation and formocresol pulpotomy | |
| Kamboj et al. | Comparative evaluation of mineral trioxide aggregate and Biodentine as pulpotomy agents in primary molars—an in vivo study | |
| Barker et al. | Reaction of dog pulp and periapical tissue to two glucocorticosteroid preparations | |
| Girish et al. | Clinical and radiographic evaluation of mineral trioxide aggregate and electrosurgical pulpotomies in primary molars: an in-vivo study | |
| Uddin et al. | Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in primary molars |